Cantor Fitzgerald Maintains Neutral on Sabra Health Care REIT, Raises Price Target to $22

Cantor Fitzgerald analyst Richard Anderson maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and raises the price target from $21 to $22.